Resolute Advisors LLC Biogen Inc. Transaction History

Resolute Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $32,468 - $41,726	-145 Closed	0 $0
Q2 2021 Dec 27, 2021	BUY	$259.0 - $414.71 $37,555 - $60,132	145 New	145 $29,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $14,504 - $23,223	-56 Closed	0 $0
Q1 2021 Dec 27, 2021	BUY	$242.95 - $284.63 $13,605 - $15,939	56 New	56 $16,000
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $1,214 - $1,423	-5 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1,181 - $1,778	5 New	5 $1,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.